LAFONTAN, M.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

Lipolytic Effects of β1-, β2-, and β3-Adrenergic Agonists in White Adipose Tissue of Mammals

CHRISTIAN CARPÉNÉ, ALAIN BOUSQUET-MÉLOU, JEAN GALITZKY, MICHEL BERLAN, MAX LAFONTAN

Journal:

Annals of the New York Academy of Sciences

Year:

1998

Language:

english

File:

PDF, 1.23 MB

english, 1998

52

LPA as a Paracrine Mediator of Adipocyte Growth and Function

CÉLINE PAGÈS, ALEXIA GIRARD, OLIVIER JEANNETON, PIERRE BARBE, CLAUDE WOLF, MAX LAFONTAN, PHILIPPE VALET, JEAN SÉBASTIEN SAULNIER-BLACHE

Journal:

Annals of the New York Academy of Sciences

Year:

2000

Language:

english

File:

PDF, 1.41 MB

english, 2000

53

Advances in adipose tissue metabolism

Journal:

International Journal of Obesity

Year:

2008

Language:

english

File:

PDF, 223 KB

english, 2008

54

Effects of a Longitudinal Training Program on Responses to Exercise in Overweight Men

Francois Crampes, Fabrice Marion-Latard, Alexia Zakaroff-Girard, Isabelle de Glisezinski, Isabelle Harant, Claire Thalamas, Vladimir Stich, Daniel Rivière, Max Lafontan, Dr. Michel Berlan

Journal:

Year:

2003

Language:

english

File:

PDF, 145 KB

english, 2003

55

Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience

Cutuli, B, Lemanski, C, Fourquet, A, de Lafontan, B, Giard, S, Meunier, A, Pioud-Martigny, R, Campana, F, Marsiglia, H, Lancrenon, S

Journal:

British Journal of Cancer

Year:

2009

Language:

english

File:

PDF, 156 KB

english, 2009

56

Lipolytic effects of conventional β3-adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative β4-adrenoceptor

Jean Galitzky, Dominique Langin, Patrick Verwaerde, Jean-Louis Montastruc, Max Lafontan, Michel Berlan

Journal:

British Journal of Pharmacology

Year:

1997

Language:

english

File:

PDF, 342 KB

english, 1997

57

Metabolic response to various β-adrenoceptor agonists in β3-adrenoceptor knockout mice: Evidence for a new β-adrenergic receptor in brown adipose tissue

Frédéric Preitner, Patrick Muzzin, Jean-Pierre Revelli, Josiane Seydoux, Jean Galitzky, Michel Berlan, Max Lafontan, Jean-Paul Giacobino

Journal:

British Journal of Pharmacology

Year:

1998

Language:

english

File:

PDF, 262 KB

english, 1998

58

Endothelin-1 inhibits TNFα-induced iNOS expression in 3T3-F442A adipocytes

Christelle Mérial-Kieny, Michel Lonchampt, Francis Cogé, Patrick Verwaerde, Jean-Pierre Galizzi, Jean A Boutin, Max Lafontan, Nigel Levens, Jean Galitzky, Michel Félétou

Journal:

British Journal of Pharmacology

Year:

2003

Language:

english

File:

PDF, 243 KB

english, 2003

59

Phosphodiesterase-5A and neutral endopeptidase activities in human adipocytes do not control atrial natriuretic peptide-mediated lipolysis

C Moro, E Klimcakova, M Lafontan, M Berlan, J Galitzky

Journal:

British Journal of Pharmacology

Year:

2007

Language:

english

File:

PDF, 188 KB

english, 2007

60

Glucose-induced sympathetic activity and energy expenditure during acute α2-adrenergic antagonism in obese subjects

Thalamas, C, Galitzky, J, Sénard, J M, Lafontan, M, Montastruc, J L, Berlan, M, Barbe, P

Journal:

International Journal of Obesity

Year:

2000

Language:

english

File:

PDF, 145 KB

english, 2000

61

Effects of hypoxia on the expression of proangiogenic factors in differentiated 3T3-F442A adipocytes

Lolmède, K, Durand de Saint Front, V, Galitzky, J, Lafontan, M, Bouloumié, A

Journal:

International Journal of Obesity

Year:

2003

Language:

english

File:

PDF, 212 KB

english, 2003

62

Adrenaline but not noradrenaline is a determinant of exercise-induced lipid mobilization in human subcutaneous adipose tissue

I. De Glisezinski, D. Larrouy, M. Bajzova, K. Koppo, J. Polak, M. Berlan, J. Bulow, D. Langin, M. A. Marques, F. Crampes, M. Lafontan, V. Stich

Journal:

The Journal of Physiology

Year:

2009

Language:

english

File:

PDF, 451 KB

english, 2009

63

Physical Activity and Exercise in the Regulation of Human Adipose Tissue Physiology

Thompson, D., Karpe, F., Lafontan, M., Frayn, K.

Journal:

Physiological Reviews

Year:

2012

Language:

english

File:

PDF, 1.81 MB

english, 2012

64

Differential recruitment and differential regulation by physiological amines of fat cell β-1, β-2 and β-3 adrenergic receptors expressed in native fat cells and in transfected cell lines

Journal:

Cellular Signalling

Year:

1994

Language:

english

File:

PDF, 2.46 MB

english, 1994

65

Discrimination between α2-adrenoceptors and [3H]idazoxan-labelled non-adrenergic sites in rabbit white fat cells

Dominique Langin, Hervé Paris, Michèle Dauzats, Max Lafontan

Journal:

European Journal of Pharmacology: Molecular Pharmacology

Year:

1990

Language:

english

File:

PDF, 999 KB

english, 1990

66

A1 adenosine receptors in the human fat cell: tissue distribution and regulation of radioligand binding

Dominique Larrouy, Jean Galitzky, Max Lafontan

Journal:

European Journal of Pharmacology: Molecular Pharmacology

Year:

1991

Language:

english

File:

PDF, 794 KB

english, 1991

67

Adipocyte α2A-adrenoceptor is the only α2-adrenoceptor regulated by testosterone

Anne Bouloumié, Philippe Valet, Daniéle Daviaud, Hervé Prats, Max Lafontan, Jean-Sébastien Saulnier-Blache

Journal:

European Journal of Pharmacology: Molecular Pharmacology

Year:

1994

Language:

english

File:

PDF, 903 KB

english, 1994

68

Coupling of inhibitory receptors with Gi-proteins in hamster adipocytes: comparison between adenosine A1 receptor and α2-adrenoceptor

Dominique Larrouy, Anne Remaury, Danièle Daviaud, Max Lafontan

Journal:

European Journal of Pharmacology: Molecular Pharmacology

Year:

1994

Language:

english

File:

PDF, 772 KB

english, 1994

69

Desensitization of β-adrenergic responses in adipocytes involves receptor subtypes and cAMP phosphodiesterase

Alain Bousquet-Mélou, Jean Galitzky, Carmen Muñoz Moreno, Michel Berlan, Max Lafontan

Journal:

European Journal of Pharmacology: Molecular Pharmacology

Year:

1995

Language:

english

File:

PDF, 1.30 MB

english, 1995

70

L'ultrasonographie à haute fréquence et le celluscore : un progrès dans l'évaluation objective du phénomène de cellulite

B. Mole, P. Blanchemaison, D. Elia, M. Lafontan, J. Mauriac, M. Mauriac, S. Mimoun, J. Raison

Journal:

Annales de Chirurgie Plastique Esthétique

Year:

2004

Language:

french

File:

PDF, 479 KB

french, 2004

71

High expression of monoamine oxidases in human white adipose tissue: evidence for their involvement in noradrenaline clearance

Nathalie Pizzinat, Luc Marti, Anne Remaury, Frederic Leger, Dominique Langin, Max Lafontan, Christian Carpéné, Angelo Parini

Journal:

Biochemical Pharmacology

Year:

1999

Language:

english

File:

PDF, 304 KB

english, 1999

72

À propos d'un cas rare de sarcome radio-induit du sein

C Denoël, L Foucras, B de Lafontan, J.-L Grolleau, J.-P Chavoin

Journal:

Annales de Chirurgie Plastique Esthétique

Year:

2003

Language:

french

File:

PDF, 575 KB

french, 2003

73

Natural history of node-negative breast cancer: are conventional prognostic factors predictors of time to relapse?

Michel Héry, Thierry Delozier, Alain Ramaioli, Jean-Pierre Julien, Brigitte de Lafontan, Thierry Petit, Catherine de Ghislain, Béatrice Weber, Jacques Bonneterre, Eric Teissier

Journal:

Year:

2002

Language:

english

File:

PDF, 185 KB

english, 2002

74

Alpha-adrenergic antilipolytic effect of adrenaline in human fat cells of the thigh: comparison with adrenaline responsiveness of different fat deposits

M. LAFONTAN, L. DANG-TRAN, M. BERLAN

Journal:

European Journal of Clinical Investigation

Year:

1979

Language:

english

File:

PDF, 551 KB

english, 1979

75

Evidence that epinephrine acts preferentially as an antilipolytic agent in abdominal human subcutaneous fat cells: assessment by analysis of beta and alpha2 adrenoceptors properties

MICHEL BERLAN, MAX LAFONTAN

Journal:

European Journal of Clinical Investigation

Year:

1985

Language:

english

File:

PDF, 775 KB

english, 1985

76

Platelet alpha2 adrenoceptors in Parkinson's disease: decreased number in untreated patients and recovery after treatment

ALAIN VILLENEUVE, MICHEL BERLAN, MAX LAFONTAN, CLAUDINE CARANOBE, BERNARD BONEU, ANDRÉ RASCOL, JEAN-LOUIS MONTASTRUC

Journal:

European Journal of Clinical Investigation

Year:

1985

Language:

english

File:

PDF, 440 KB

english, 1985

77

α2-Antagonist compounds and lipid mobilization: evidence for a lipid mobilizing effect of oral yohimbine in healthy male volunteers

J. GALITZKY, M. TAOUIS, M. BERLAN, D. RIVIÈRE, M. GARRIGUES, M. LAFONTAN

Journal:

European Journal of Clinical Investigation

Year:

1988

Language:

english

File:

PDF, 834 KB

english, 1988

78

Regulation of beta3-adrenoceptor expression in white fat cells

D. Langin, G. Tavernier, M. Lafontan

Journal:

Fundamental & Clinical Pharmacology

Year:

1995

Language:

english

File:

PDF, 1.00 MB

english, 1995

79

Differential activation of β1-, β2- and β3-adrenoceptors by catecholamines in white and brown adipocytes

J. Galitzky, C. Carpéné, A. Bousquet-Mélou, M. Berlan, M. Lafontan

Journal:

Fundamental & Clinical Pharmacology

Year:

1995

Language:

english

File:

PDF, 696 KB

english, 1995

80

Human adipocytes express α2-adrenergic receptor of the α2A-subtype only: pharmacological and genetic evidence

I. Castan, JC Devedjian, P. Valet, H. Paris, M. Lafontan

Journal:

Fundamental & Clinical Pharmacology

Year:

1995

Language:

english

File:

PDF, 574 KB

english, 1995

81

In situ assessment of the role of the β1, β2- and β3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue

Pierre Barbe, Laurence Millet, Jean Galitzky, Max Lafontan, Michel Berlan

Journal:

British Journal of Pharmacology

Year:

1996

Language:

english

File:

PDF, 1.40 MB

english, 1996

82

Adrenergic Receptors and Fat Cells: Differential Recruitment by Physiological Amines and Homologous Regulation

Dr. Max Lafontan, Alain Bousquet-Melou, Jean Galitzky, Pierre Barbe, Christian Carpéné, Dominique Langin, Michel Berlan, Philippe Valet, Isabelle Castan, Anne Bouloumié, Jean-Sébastien Saulnier-Blache

Journal:

Year:

1995

Language:

english

File:

PDF, 958 KB

english, 1995

83

Functional Consequences of Constitutively Active α2A-Adrenergic Receptor Expression in 3T3F442A Preadipocytes and Adipocytes

Sandrine Bétuing, Philippe Valet, Sophie Lapalu, Delphine Peyroulan, Gilles Hickson, Danièle Daviaud, Max Lafontan, Jean Sébastien Saulnier-Blache

Journal:

Biochemical and Biophysical Research Communications

Year:

1997

Language:

english

File:

PDF, 639 KB

english, 1997

84

Ca2+-Independent Phospholipase A2 Is Required for α2-Adrenergic-Induced Preadipocyte Spreading

Céline Pagès, Astrid Rey, Max Lafontan, Philippe Valet, Jean Sébastien Saulnier-Blache

Journal:

Biochemical and Biophysical Research Communications

Year:

1999

Language:

english

File:

PDF, 88 KB

english, 1999

85

Non-adrenergic sites for imidazolines are not directly involved in the α2-adrenergic antilipolytic effect of UK 14304 in rat adipocytes

Christian Carpéné, Jean Galitzky, Dominique Larrouy, Dominique Langin, Max Lafontan

Journal:

Biochemical Pharmacology

Year:

1990

Language:

english

File:

PDF, 1021 KB

english, 1990

86

Identification of α2-adrenergic receptors in human fat cell membranes by [3H]chlonidine binding

Michel Berlan, Max Lafontan

Journal:

European Journal of Pharmacology

Year:

1980

Language:

english

File:

PDF, 327 KB

english, 1980

87

Evidence for the α2 nature of the α-adrenergic receptor inhibiting lipolysis in human fat cells

Max Lafontan, Michel Berlan

Journal:

European Journal of Pharmacology

Year:

1980

Language:

english

File:

PDF, 589 KB

english, 1980

88

Characterization of physiological agonist selectivity of human fat cell α2-adrenoceptors: Adrenaline is the major stimulant of the α2-adrenoceptors

Max Lafontan, Michel Berlan

Journal:

European Journal of Pharmacology

Year:

1982

Language:

english

File:

PDF, 376 KB

english, 1982

89

Imidazolinic radioligands for the identification of hamster adipocyte α2-adrenoceptors

Jean-Sébastien Saulnier-Blache, Christian Carpéné, Dominique Langin, Max Lafontan

Journal:

European Journal of Pharmacology

Year:

1989

Language:

english

File:

PDF, 1.01 MB

english, 1989

90

[3H]Idazoxan binding at non-α2-adrenoceptors in rabbit adipocyte membranes

Dominique Langin, Max Lafontan

Journal:

European Journal of Pharmacology

Year:

1989

Language:

english

File:

PDF, 342 KB

english, 1989

91

[3H]RX821002: a new tool for the identification of α2A-adrenoceptors

Dominique Langin, Max Lafontan, Mike R. Stillings, Hervé Paris

Journal:

European Journal of Pharmacology

Year:

1989

Language:

english

File:

PDF, 733 KB

english, 1989

92

Evaluation of sympathetic nervous system activity and alpha2-adrenergic receptivity in obese subjects

J. Galitzky, P. Barbe, D. Rivière, J.-M. Senard, M. Lafontan, M.-A. Tran, M. Berlan

Journal:

European Journal of Pharmacology

Year:

1990

Language:

english

File:

PDF, 215 KB

english, 1990

93

Coexistence of three β-adrenoceptor subtypes in white fat cells of various mammalian species

Dominique Langin, Maria P. Portillo, Jean-Sébastien Saulnier-Blache, Max Lafontan

Journal:

European Journal of Pharmacology

Year:

1991

Language:

english

File:

PDF, 1.36 MB

english, 1991

94

A specific β3-adrenoceptor agonist induces increased pancreatic islet blood flow and insulin secretion in rats

Nadia Atef, Max Lafontan, Alexandre Double, Christophe Hélary, Alain Ktorza, Luc Pénicaud

Journal:

European Journal of Pharmacology

Year:

1996

Language:

english

File:

PDF, 541 KB

english, 1996

95

Male breast cancer: Results of the treatments and prognostic factors in 397 cases

B. Cutuli, M. Lacroze, J.M. Dilhuydy, M. Veiten, B. De Lafontan, C. Marchal, M. Resbeut, Y. Graic, F. Campana, V. Moncho-Bernier, C. De Gislain, J. Tortochaux, J.C. Cuillere, M. Reme-Saumon, T.D. N'Gu

Journal:

European Journal of Cancer

Year:

1995

Language:

english

File:

PDF, 600 KB

english, 1995

96

770 Breast cancer (BC) after hodgkin's disease (HD). Analysis of 35 cases

B. Cutuli, A. De la Rochefordiere, Y. Graic, B. De Lafontan, J.M. Dilhuydy, T.D. N’Guyen, P. Bey

Journal:

European Journal of Cancer

Year:

1995

Language:

english

File:

PDF, 136 KB

english, 1995

97

PP-5-6 Castration and Tamoxifen Versus Chemotherapy (FAC) for Premenopausal, Node and Receptors Positive Breast Cancer Patients: A Randomized Trial with a 7 Years Median Follow Up

H. Roché, J. Mihura, B. de Lafontan, M. Reme-Saumon, P. Martel, J-B. Dubois, A. Naja

Journal:

European Journal of Cancer

Year:

1996

Language:

english

File:

PDF, 184 KB

english, 1996

98

PP-5-12 Intensive chemotherapy program with autologous bone marrow transplantation (ABMT) in non metastatic inflammatory breast cancer: Mature results

H. Roche, C. Chevreau, J. Mihura, T. Facchini, J.M. Reme, A. Marre, F. Bonnet, B. de Lafontan, R. Bugat

Journal:

European Journal of Cancer

Year:

1996

Language:

english

File:

PDF, 179 KB

english, 1996

99

Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity

Carine Duffaut, Jean Galitzky, Max Lafontan, Anne Bouloumié

Journal:

Biochemical and Biophysical Research Communications

Year:

2009

Language:

english

File:

PDF, 239 KB

english, 2009

100

Attitudes chirurgicales et radiothérapiques en fonction de l’analyse des berges–marges dans les tumeurs mammaires : enquête réalisée auprès de 20 centres de lutte contre le cancer

C. Hanzen, B. de Lafontan, F. Missohou, C. Veyret, S. Laberge, J.M. Picquenot, Y. Graïc

Journal:

Cancer/Radiothérapie

Year:

2004

Language:

french

File:

PDF, 144 KB

french, 2004